It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19).
作者信息
Timothée Klopfenstein, Gerazime Aurélie, Puyraveau Marc, Kadiane-Oussou N'dri Juliette, Gendrin Vincent, Zayet Souheil
机构信息
Infectious Disease Department, Nord Franche-Comté Hospital, Trevenans, France.
Methodology Unit, Clinical Investigation Center, INSERM 1431, Jean-Minjoz University Hospital, Besançon, France.
出版信息
Clin Infect Dis. 2022 Feb 11;74(3):560-562. doi: 10.1093/cid/ciab480.
Abstract
摘要
相似文献
1
It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19).是时候确定托珠单抗在2019冠状病毒病（COVID-19）中的地位了。
Clin Infect Dis. 2022 Feb 11;74(3):560-562. doi: 10.1093/cid/ciab480.
2
Tocilizumab's efficacy in patients with Coronavirus Disease 2019 (COVID-19) is determined by the presence of cytokine storm.托珠单抗在2019冠状病毒病（COVID-19）患者中的疗效取决于细胞因子风暴的存在情况。
J Med Virol. 2021 Jan;93(1):120-121. doi: 10.1002/jmv.26209. Epub 2020 Jun 29.
3
Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia.重新评估托珠单抗在新冠肺炎肺炎中作用的时机
JAMA Intern Med. 2021 Jan 1;181(1):12-15. doi: 10.1001/jamainternmed.2020.6557.
4
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review.托珠单抗在妊娠期和哺乳期 COVID-19 中的应用：一篇叙述性综述。
Clin Microbiol Infect. 2022 Jan;28(1):51-57. doi: 10.1016/j.cmi.2021.08.016. Epub 2021 Aug 23.
5
Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations.托珠单抗在皮肤科中有作用吗？临床应用、不良反应及实际考虑的综述。
Dermatol Ther. 2021 Jul;34(4):e14990. doi: 10.1111/dth.14990. Epub 2021 May 25.
6
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者：一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
7
Association of injection Tocilizumab and inflammatory markers in COVID19.COVID19 中注射托珠单抗与炎症标志物的关系。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
8
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.托珠单抗治疗 5 例 SARS-CoV-2 导致早期 ARDS 的实体和复合组织移植受者。
Am J Transplant. 2020 Nov;20(11):3191-3197. doi: 10.1111/ajt.16080. Epub 2020 Jul 22.
9
Tocilizumab in Coronavirus Disease 2019: Give It Time!托珠单抗治疗冠状病毒病2019：给它一些时间！
Clin Infect Dis. 2021 Dec 16;73(12):2368-2369. doi: 10.1093/cid/ciab081.
10
An update of antispike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies.抗刺突严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）单克隆抗体的更新。
Indian J Pharmacol. 2022 Jan-Feb;54(1):51-57. doi: 10.4103/ijp.ijp_519_21.
引用本文的文献
1
Brain fog across the Mediterranean.地中海地区的脑雾现象。
Infect Med (Beijing). 2024 Sep 26;3(4):100140. doi: 10.1016/j.imj.2024.100140. eCollection 2024 Dec.
2
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.分析预测重症 COVID-19 患者对托珠单抗治疗临床应答的因素。
Int J Infect Dis. 2022 Apr;117:56-64. doi: 10.1016/j.ijid.2022.01.040. Epub 2022 Jan 23.
Zotero 插件